The authors report on the extended follow-up of Courage Trial patients for up to 15 years. In this trial, patients with chronic stable angina were randomized to medical therapy alone versus PCI plus medical therapy. At extended follow-up, there was no difference in overall survival between the two treatment strategies.
You are here:
Effect of PCI on Long-Term Survival in Patients with Stable Ischemic Heart Disease
Submitted by: Arie Blitz
Source: New England Journal of Medicine
Keywords:
Author(s): Steven P. Sedlis, Pamela M. Hartigan, Koon K. Teo, David J. Maron, John A. Spertus, G.B. John Mancini, William Kostuk, Bernard R. Chaitman, Daniel Berman, Jeffrey D. Lorin, Marcin Dada, William S. Weintraub, and William E. Boden for the COURAGE Trial Investigators
